Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
22,970,618
-
Share change
-
+6,833,927
-
Total reported value
-
$112,327,494
-
Put/Call ratio
-
12%
-
Price per share
-
$4.89
-
Number of holders
-
71
-
Value change
-
+$30,416,195
-
Number of buys
-
44
-
Number of sells
-
21
Institutional Holders of KALA BIO INC COM NEW - Stock (KALA) as of Q4 2018
As of 31 Dec 2018,
KALA BIO INC COM NEW - Stock (KALA) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,970,618 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., CAXTON CORP, Athyrium Capital Management, LP, Vivo Capital, LLC, Vanguard Group Inc, and Sofinnova Investments, Inc..
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.